At NATA, collaboration is the foundation of our ethos and business model. We work with world-leading academics, clinicians, businesses, start-ups, SMEs, pharma biotech and charities bringing together a diverse network of expertise, skills and innovative technologies to bridge translational gaps in NAT development.
At our core, we are a passionate team of chemists and biologists dedicated to the successful development of nucleic acid therapies. We incorporate novel innovations to improve the targeted delivery, efficacy, and safety profile of these exciting new drugs. Our interdisciplinary approach through the convergence of chemistry and biology, facilitates the transition from in vitro experimentation to in vivo application.
At the NATA Hub, we are always open to new collaborations and partnerships. We provide end-to-end support for projects, applying our resources, knowledge and expertise with the agility to initiate new projects and collaborations quickly and efficiently.
In addition, we fund two Research Challenge consortia to address critical issues in the delivery and manufacture of NATs: TransNAT & BioManNAT.
If you are interested in working with us, please contact us.